China’s contraception market exceeded 30 billion RMB in 2024, combining pharmaceutical contraceptives, medical devices, and consumer health products. The market is growing at approximately 8-12% annually, driven by shifting attitudes toward family planning, rising awareness of reproductive health among young Chinese consumers, and a generation of post-90s and post-00s consumers who approach contraception differently from previous generations — as a health choice rather than a purely clinical matter.
For international health and consumer brands in the contraception, sexual health, and reproductive health categories, China’s evolving market represents a genuine opportunity — with specific regulatory requirements, channel dynamics, and consumer communication approaches that differ substantially from Western markets.
Market Structure and Consumer Segments
China’s contraception market divides across three main product segments:
Condoms: The Dominant Category
Condoms account for the majority of China’s consumer contraception market by unit volume. The category is dominated by international brands (Durex leads with approximately 20-25% market share, followed by Okamoto, Jissbon, and others) with a substantial domestic segment at lower price points. The condom market in China has professionalized significantly over the past decade — products are sold through Tmall, JD, convenience stores, and pharmacies rather than being limited to specialist retail. Durex has built one of the most widely admired social media presences in China for any consumer health brand through its Weibo and WeChat official account content: irreverent, sex-positive, and culturally aware communication that resonated with young Chinese consumers in an era when most health brands communicated cautiously.
Hormonal Contraceptives
Oral contraceptives in China are classified as prescription pharmaceuticals (处方药 — chǔfāng yào) and require a doctor’s prescription for purchase in offline pharmacy settings. However, the online pharmaceutical platform ecosystem (JD Health, Ali Health, and dedicated online pharmacy platforms) has made prescription fulfillment significantly more accessible — consumers can consult with an online doctor and receive a same-day prescription for oral contraceptives through these platforms. International pharmaceutical companies including Bayer (Yasmin/YAZ brands) and Merck have established China prescription contraceptive operations. The prescription-online intersection is one of the faster-growing dynamics in this category.
Sexual Wellness and Femtech
A newer and faster-growing segment in the broader contraception and reproductive health space covers: emergency contraception (available over-the-counter in Chinese pharmacies), menstrual health and period care products, fertility monitoring technology, and sexual wellness devices. This segment overlaps with broader femtech trends and is characterized by younger consumer demographics, higher price sensitivity to premium positioning, and strong growth driven by Xiaohongshu and Bilibili content normalization of conversations about sexual and reproductive health among young Chinese women.
Consumer Attitude Shifts
Chinese consumer attitudes toward contraception and sexual health have changed substantially across generational cohorts. The post-90s (millennials born 1990-1999) and post-00s (Gen Z, born after 2000) demographic segments are:
Written by
Harry
Harry covers Chinese social platforms and e-commerce at E-Commerce China Agency, with a focus on Baidu, Weibo, Xiaohongshu and Douyin. He writes about how foreign brands actually build visibility on those channels: what earns traction, what burns budget, and why. Much of his work centres on the health, supplements and FMCG categories entering the Chinese market.
Related Articles
Health
Digestive Supplements in China: Market Summary & Top Trends
Digestive health supplements are one of the largest and fastest-growing categories in China’s health product market. The segment — covering probiotics, digestive enzymes, fiber supplements, prebiotic products, and traditional Chinese medicine (TCM) digestive formulas — exceeded 50 billion RMB in 2024 and is growing at 15-20% annually. China’s digestive supplement market is distinctive in its […]
Read more →
Vitamins & Supplements
China: NMN getting popular on Chinese ECommerce App
NMN (nicotinamide mononucleotide) became one of the fastest-growing supplement categories in China between 2020 and 2024. From a niche product known only among longevity researchers, NMN expanded into a mass-premium supplement category driven by celebrity endorsements, Xiaohongshu content about anti-aging science, and a Chinese consumer base already primed for premium health supplements through years of […]
Read more →
Sectors
Distribution in China: A Comprehensive Guide
Distribution in China is the operational infrastructure that determines whether a product gets to Chinese consumers — and in what condition, at what price, and through which channels. For international brands, the distribution question is one of the most consequential early decisions in China market entry: choose the wrong partner or the wrong model, and […]
Read more →